跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

06735

Supelco

叔丁基二甲基氯硅烷

for GC derivatization, LiChropur™, ≥99.0% (GC)

别名:

TBDMSCl, 叔丁基(氯)二甲基硅烷, 叔丁基二甲基氯硅烷

登录查看公司和协议定价
所有图片(1)

About This Item

线性分子式:
(CH3)3CSi(CH3)2Cl
CAS号:
18162-48-6
分子量:
150.72
Beilstein:
505999
EC 号:
242-042-4
MDL编号:
MFCD00000501
UNSPSC代码:
41116105
PubChem化学物质编号:
329748269
NACRES:
NA.22

等级

derivatization grade ((GC derivatization))
for GC derivatization

质量水平

100

方案

≥99.0% (GC)

质量

LiChropur™

反应适用性

reagent type: derivatization reagent
reaction type: Silylations

技术

gas chromatography (GC): suitable

沸点

125 °C (lit.)

mp

86-89 °C (lit.)

SMILES字符串

CC(C)(C)[Si](C)(C)Cl

InChI

1S/C6H15ClSi/c1-6(2,3)8(4,5)7/h1-5H3

InChI key

BCNZYOJHNLTNEZ-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

推荐产品

Discover LiChropur™ reagents ideal for HPLC or LC-MS analysis

法律信息

LiChropur is a trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

19905

叔丁基(氯)二甲基硅烷, ≥95.0% (GC)

394882

N - 叔 -丁基二甲基硅基- N -甲基三氟乙酰胺, >97%

190500

叔丁基二甲基氯硅烷, reagent grade, 97%

375934

N-叔丁基二甲基甲硅烷基-N-甲基三氟乙酰胺，含 1% 叔丁基二甲基氯硅烷, ≥95%

473464

叔丁基氯二甲基硅烷 溶液, 50 wt. % in toluene

384429

叔丁基二甲基硅基氯 溶液, 1.0 M in methylene chloride

372951

叔丁基二甲基硅基氯 溶液, 1.0 M in THF

226149

叔丁基二甲基硅基三氟甲磺酸酯, reagent grade, 98%

250236

1-(叔丁基二甲基甲硅烷基)咪唑, ≥95%

33092-U

叔丁基二甲基哇烷基咪唑 溶液, TBDMSIM in DMF, pkg of 10 × 1 mL

56563

叔丁基二甲基硅基三氟甲磺酸酯, for GC derivatization, LiChropur™, ≥98.0% (T)

77626

N - 叔 -丁基二甲基硅基- N -甲基三氟乙酰胺, for GC derivatization, LiChropur™, ≥98.0% (GC)

00942

N-叔丁基二甲基甲硅烷基-N-甲基三氟乙酰胺，含 1% 叔丁基二甲基氯硅烷, for GC derivatization, LiChropur™, ≥95.0% (GC)

44795

N,O-双（叔丁基二甲基甲硅烷基）乙酰胺, for GC derivatization, LiChropur™, ≥98.0% (GC)

警示用语：

Danger

危险声明

H228,H314,H411

危险分类

Aquatic Chronic 2 - Eye Dam. 1 - Flam. Sol. 1 - Skin Corr. 1A

储存分类代码

4.1B - Flammable solid hazardous materials

WGK

WGK 2

闪点(°F)

71.6 °F - closed cup

闪点(°C)

22 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCH1883
BCBW0867
BCCB4665
BCBZ9530
BCBT6588

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Hiroaki Wakimoto et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2898-2909 (2014-04-10)
Isocitrate dehydrogenase (IDH) gene mutations occur in low-grade and high-grade gliomas. We sought to identify the genetic basis of malignant phenotype heterogeneity in IDH-mutant gliomas. We prospectively implanted tumor specimens from 20 consecutive IDH1-mutant glioma resections into mouse brains and
Some observations on the t-butyldimethylchlorosilane derivatization reaction.
K Bricknell et al.
Biochemical medicine, 23(1), 119-121 (1980-02-01)
P Huttenloch et al.
Environmental science & technology, 35(21), 4260-4264 (2001-11-23)
The efficacy of the surface modification of natural diatomite and zeolite material by chlorosilanes is demonstrated. Chlorosilanes used were trimethylchlorosilane (TMSCI), tert-butyldimethylchlorosilane (TBDMSCI), dimethyloctadecylchlorosilane (DMODSCI), and diphenyldichlorosilane (DPDSCI) possessing different headgroups and chemical properties. Silanol groups of the diatomite and
Rie Harboe Nielsen et al.
Journal of applied physiology (Bethesda, Md. : 1985), 117(7), 694-698 (2014-08-12)
The classic form of Ehlers-Danlos syndrome (cEDS) is an inherited connective tissue disorder, where mutations in type V collagen-encoding genes result in abnormal collagen fibrils. Thus the cEDS patients have pathological connective tissue morphology and low stiffness, but the rate
C Tellis et al.
Journal of biochemistry, 119(4), 823-827 (1996-04-01)
1-O-Hexadecyl-2-acetyl-sn-glycerol, the immediate precursor of platelet- activating factor (PAF) in its de novo formation, was detected in the protozoon Tetrahymena pyriformis. It was purified from the total lipid extract by TLC, after successive developments in two different solvent systems. Characterization
查看所有相关文献

商品

Silylation of Non-Steroidal Anti-Inflammatory Drugs

Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs

Silylation of Non-Steroidal Anti-Inflammatory Drugs

Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs

Silylation of Non-Steroidal Anti-Inflammatory Drugs

Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs

Silylation of Non-Steroidal Anti-Inflammatory Drugs

Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门